NEGRINI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 20.778
EU - Europa 5.775
AS - Asia 3.606
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
SA - Sud America 6
AF - Africa 4
Totale 30.188
Nazione #
US - Stati Uniti d'America 20.762
CN - Cina 2.077
IT - Italia 1.340
UA - Ucraina 1.302
DE - Germania 897
TR - Turchia 854
GB - Regno Unito 611
PL - Polonia 496
SG - Singapore 423
SE - Svezia 417
FI - Finlandia 298
FR - Francia 111
BE - Belgio 91
VN - Vietnam 85
ID - Indonesia 67
CZ - Repubblica Ceca 54
RU - Federazione Russa 48
RO - Romania 31
IR - Iran 26
HK - Hong Kong 25
NL - Olanda 24
IN - India 23
AT - Austria 20
CA - Canada 15
KR - Corea 10
IE - Irlanda 9
AU - Australia 8
EU - Europa 8
CH - Svizzera 7
JP - Giappone 5
ES - Italia 4
GR - Grecia 4
BR - Brasile 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CL - Cile 2
GH - Ghana 2
PT - Portogallo 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
CV - Capo Verde 1
DK - Danimarca 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TN - Tunisia 1
Totale 30.188
Città #
Fairfield 2.943
Woodbridge 2.756
Houston 1.850
Chandler 1.546
Jacksonville 1.501
Ashburn 1.430
Ann Arbor 1.188
Seattle 1.074
Wilmington 1.021
Cambridge 903
Izmir 561
Warsaw 493
Nanjing 467
Beijing 466
Ferrara 354
Princeton 346
New York 324
San Diego 272
Boardman 243
Singapore 222
Shanghai 197
Milan 189
Nanchang 140
Shenyang 128
Bremen 110
Dearborn 103
Tianjin 92
Addison 90
Falls Church 87
Brussels 84
Dong Ket 81
Changsha 73
Hebei 71
Jiaxing 68
Jakarta 65
Mountain View 61
Jinan 60
San Mateo 55
Kunming 51
Redwood City 48
London 47
Brno 45
Washington 45
Norwalk 44
Los Angeles 43
Bologna 39
Ningbo 39
Zhengzhou 37
Auburn Hills 34
Rome 33
Guangzhou 32
Tappahannock 29
Verona 29
Augusta 27
Hangzhou 26
Orange 26
Des Moines 25
Philadelphia 25
Hong Kong 22
Leawood 22
Hefei 21
Indiana 18
Vienna 18
Taizhou 17
Timisoara 17
Lanzhou 16
Napoli 16
Ardabil 15
Changchun 15
Monmouth Junction 13
Redmond 13
Helsinki 12
Kilburn 12
Naples 12
Chicago 10
Monte San Pietro 10
Amsterdam 9
Bari 8
Dublin 8
Ferrara di Monte Baldo 8
Haikou 8
Palermo 8
Acton 7
San Giorgio Di Piano 7
San Jose 7
Toronto 7
Hounslow 6
Munich 6
Prescot 6
San Francisco 6
Trieste 6
Lappeenranta 5
Messina 5
Monza 5
Olomouc 5
Reggio Emilia 5
Walnut 5
Brescia 4
Casalecchio Di Reno 4
Catania 4
Totale 22.866
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 524
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 287
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 223
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 179
Absolute quantification of cell-free microRNAs in cancer patients 178
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 171
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 168
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 161
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 159
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 154
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 154
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 151
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 148
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 147
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 146
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 145
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 145
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 142
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 139
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 139
MicroRNA e cancro 138
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 135
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 135
null 132
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 132
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 131
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 130
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 130
Refined subchromosomal location of 21 expressed sequence tags from unknown genes at region 11p15 129
null 128
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 128
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 128
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 127
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 126
Circulating non-coding RNA as biomarkers in colorectal cancer 126
MicroRNA involvement in hepatocellular carcinoma 125
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 125
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 125
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 123
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 123
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 123
Tumor suppressor functions of ARLTS1 in lung cancers 122
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 122
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 121
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 121
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 121
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 120
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 119
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 119
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 119
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 119
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 119
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 119
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 118
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 117
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 117
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 117
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 116
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 116
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 115
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 115
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
Extensive modulation of a set of microRNAs in primary glioblastoma 114
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 114
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 112
Reprogramming of miRNA networks in cancer and leukemia 112
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 112
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 111
null 111
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 111
Evidence for BK virus as a human tumor virus 111
NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15) 111
MicroRNA deregulation in human thyroid papillary carcinomas 111
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 111
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 111
Regulatory mechanisms of microRNAs involvement in cancer 111
MicroRNA response to environmental mutagens in liver 111
Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 110
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 110
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 109
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 109
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 109
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 109
null 109
Animal Models of Hepatocellular Carcinoma Prevention 108
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 108
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4 107
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 107
Evidence for BK virus as a human tumor virus. 107
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 107
null 107
Minor myeloid component in Ph chromosome-positive acute lymphoblastic leukaemia: correlation with cytogenetic pattern and implication for poor response to therapy 106
Simian virus 40 infection in humans and association with human diseases: results and hypotheses 106
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 106
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers 106
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 106
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 106
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 106
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 106
Totale 12.999
Categoria #
all - tutte 123.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.095
Totale 128.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.844 1.042 222 208 1.018 492 813 632 676 571 697 293 180
2020/20214.955 399 436 345 503 209 470 202 510 126 692 701 362
2021/20223.752 139 356 300 169 193 188 217 219 122 271 360 1.218
2022/20233.610 390 233 128 466 604 522 162 301 454 32 189 129
2023/20242.169 187 245 95 58 169 498 112 186 44 42 59 474
2024/2025180 180 0 0 0 0 0 0 0 0 0 0 0
Totale 30.689